AI assistant
DEXCOM INC — Director's Dealing 2020
Jul 27, 2020
30198_dirs_2020-07-27_b8ac91cb-186a-4783-a8ce-b077daf2a464.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-07-23
Reporting Person: DOUBLEDAY RICHARD (EVP Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-23 | Common Stock | S | 200 | $421.615 | Disposed | 4391 | Indirect |
| 2020-07-23 | Common Stock | S | 83 | $424.63 | Disposed | 4308 | Indirect |
| 2020-07-23 | Common Stock | S | 94 | $425.99 | Disposed | 4214 | Indirect |
| 2020-07-23 | Common Stock | S | 476 | $427.36 | Disposed | 3738 | Indirect |
| 2020-07-23 | Common Stock | S | 107 | $428.5164 | Disposed | 3631 | Indirect |
| 2020-07-23 | Common Stock | S | 571 | $429.6019 | Disposed | 3060 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 51482 | Direct |
Footnotes
F1: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
F3: This transaction was executed in multiple trades at prices ranging from $427.20 to $428.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: This transaction was executed in multiple trades at prices ranging from $428.24 to $428.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $429.38 to $429.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.